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Background: During the last decades, the number of people suffering from dermatophytoses has seriously
increased, mainly due to the development of resistant strains of microorganisms to a range of formally efficient
antibiotics. Polyscias fulva, a medium size tree which grows in the West Region of Cameroon is traditionally used for
local application against dermatoses and orally against venereal infections. The dichloromethane-methanol (1:1 v/v)
extract from the stem bark of Polyscias fulva was evaluated for its in vitro and in vivo antifungal activities.
Methods: The plant extract was prepared by maceration of its stem bark powder in CH2Cl2-MeOH (1:1 v/v). The
extract obtained was successively partitioned in hexane, ethyl acetate and n-butanol. Phytochemical screening was
performed using standard methods. In vitro antidermatophytic activity was assayed by the well diffusion and broth
microdilution methods. The degree of dermal irritation of the crude extract was determined in guinea pigs using
the occluded dermal irritation test method. The in vivo antidermatophytic activity of the extract-oil formulation
(1.25, 2.5 and 5% w/w concentrations) was evaluated using Trichophyton mentagrophytes-induced dermatophytosis
in a guinea pigs model.
Results: Phytochemical screening indicated that, the crude extract, ethyl acetate, n-butanol and residue fractions contain
in general saponins, tannins, alkaloids, anthraquinones and phenols while the hexane fraction contains only alkaloids. The
ethyl-acetate, n-butanol and residue fractions displayed higher antifungal activities (MIC = 0.125-0.5 mg.mL-1) against
eight dermatophytes as compared to the crude extract (MIC = 0.5-1 mg.mL-1). This latter appeared to have slight
perceptible erythema effects on guinea pigs as the primary irritation index (PII) was calculated to be 0.54. In vivo, the
antidermatophytic activities of the extract-oil formulations were dose-dependent. Griseofulvin-oil 5% at 0.01 g/kg and
formulated extract-oil (5%) at 0.1 g/kg eradicated the microbial infection after thirteen and fourteen days of daily
treatment respectively.
Conclusions: The results of preclinical in vitro and in vivo evaluations indicate that the extract-oil formulation at 5%
may constitute an alternative means to alleviate fungal infections caused by dermatophytes.
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Dermatophytic infections, often referred to as ringworm
and tinea are known to cause universal affliction of hu-
mans and their domestic animals. Dermatophytes colonize
the skin, nails, and hair of human populations together
with similar infections on animal hides, hooves, feathers,
beaks, and other dermal appendages [1]. Dermatophytes
thus affect keratinous tissues of humans and other verte-
brates, causing superficial infections. These microorga-
nisms belong to three genera: Trichophyton, Microsporum
and Epidermophyton [1]. Dermatophytoses generally com-
ply with topical antifungal therapy, although local therapy
may be inappropriate for extensive infections or for infec-
tions affecting the nails or scalp. In recent years, a number
of antifungal agents have been introduced into clinical
practice including griseofulvin, terbinafine, itraconazole,
fluconazole, and more recently voriconazole [1,2]. How-
ever, their spectrum of action is narrow and also many of
them have adverse side effects [3,4]. The treatment of
these infections is often long and expensive, and there
have been increasing reports of antifungal resistance [5].
Thus, there is a need for the search for new sources
of antidermatophytic substances. Herbal medicines have
been widely used and form an integral part of primary
health care in many countries [6], and may constitute a
reservoir of new antifungal substances. According to
World Health Oganisation, medicinal plants would be the
best source of a variety of drugs [7]. About 80% of the
total population in developing countries relies on trad-
itional medicines based on plant products [8]. Unfortu-
nately, their traditional use remains empirical, doses and
durations of treatment for example are not clearly defined.
There is therefore need for chemical and pharmacological
studies that may help to achieve the standardization of
such treatment. This explains why numerous studies have
been conducted on various medicinal plant extracts with
the hope of discovering new and more efficient antifungal
compounds.
Among these plants is Polyscias fulva, a medium size
tree which grows in the tropical forests of West and
Central Africa, and is traditionally used to treat malaria
and mental illness [9]. In Cameroon, a decoction of the
stem bark of Polyscias fulva bark is traditionally taken or-
ally against venereal infections [10]. Furthermore, its stems
and leaves are pounded and used for local application
against dermatoses. Phytochemical analyses revealed the
presence of triterpenes glycosides [11] and others com-
pounds like Lichexantone, 3-o-β-D-glucopyranosyl-stig-
masterol, 3-α-L-arabino-pyranosyl-hederagenin (cauloside
A), α-hederin and kalopanax-saponin B [12] from the
aerial part of the plant. Based on traditional uses of this
plant, we believe that the extract could possess anti-
dermatophytic proprieties and an oil-extract formulation
may be effective in the treatment of dermatophyticinfection. Several similar studies have been conducted and
showed the relative effectiveness of such preparations. For
example, we can mention the work on the essential oil of
Chenopodium ambrosioides [13], Zataria multiflora [14]
and Eucalyptus camaldulensis [15]. The main difficulty of
such a study is the induction of dermatophytosis in a sui-
table animal model.
To the best of our knowledge, no work exists on the
antidermatophytic activity of this plant. Thus, the present
study was undertaken to evaluate the in vitro and in vivo
antifungal activities of the dichloromethane-methanol
(1:1v/v) extract from the stem bark of Polyscias fulva.Methods
Plant material
The stem bark of Polyscias fulva (Hiern) was collected
in April 2008 at Bazou (Nde Division, West Region,
Cameroon). Botanical identification was done at the
Cameroon National Herbarium in Yaoundé by Mr
Tadjouteu Fulber and where a voucher specimen was
kept under the reference number 43546/HNC.Microorganisms
Tests were performed on eight dermatophytes: four
clinical isolates including Microsporum audouinii from
the “Centre Pasteur” of Yaoundé, Trichophyton rubrum
from the “Centre Pasteur” of Paris, Trichophyton ajelloi
and Trichophyton equinum from “Ecole Nationale
Vétérinaire d’Aford” in France; four strains including
Trichophyton mentagrophytes (E 1425), Trichophyton
terrestre (E 1501), Trichophyton Microsporum gypseum
(E 1420) and Epidermophyton floccosum (E 1423), all
from “Ecole Nationale Vétérinaire d’Aford” in France.
The strains have been maintained in the refrigerator at
4°C on agar slant as previously described [16].Animals
The dermal irritation test and the in vivo Anti-
dermatophytic activity of the crude extract were per-
formed using adult guinea pigs of both sexes (400 ±
50 g) bred in the Animal House of the Department of
Biochemistry, University of Dschang, Cameroon. The
animals were fed with standard guinea pig feed and
water ad libitum throughout the experimental period.
Animals were exposed to natural room temperature
(22±2°C) and were handled according to standard pro-
tocols for the use of laboratory animals [17,18]. Ani-
mals were randomly selected and caged individually or
in a group, depending on the type of assay, for 5 days
prior to the start of the test for acclimatization to the
test conditions. They were also randomly assigned to
control and test groups.
Table 1 Infection and treatment of guinea pigs
Group Group type Infection Treatment
1 Simple control No No
2 Negative control Yes No
3 Palm kernel oil control Yes 0.1 g/kg of palm kernel oil
(the vehicle)
4 Positive control Yes 0.01 g/kg of griseofulvin-oil
at 5%
5 Test Yes 0.1 g/kg of extract-oil at
1.25% (w/w)
6 Test Yes 0.1 g/kg of extract-oil at
2.5% (w/w)
7 Test Yes 0.1 g/kg of extract-oil at
5% (w/w)
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The stem barks of P. fulva were dried at room tem-
perature (20–24°C) for fifteen days and powdered to
coarse particles. Four kilograms of powder were macer-
ated in 10 L of the dichloromethane-methanol (Merck)
(1:1 v/v) mixture for two days with frequent stirring and
this process was repeated twice on the residue. After fil-
tration, using Wathmann filter paper N° 1, the filtrate
was evaporated to dryness under vacuum at 45°C using
a rotary evaporator (Büchi R200). The obtained crude
extract (263 g) obtained was then partitioned succes-
sively in hexane, ethyl acetate and n-butanol to obtain
the hexane (27.25 g), ethyl acetate (23.77 g), n-butanol
(16 g) and residue (195.98 g) fractions after solvent evap-
oration. The percentages of crude extract and fractions
are reported with respect to the plant material and crude
extract respectively. The number of compounds in the
crude extract and fractions were estimated based on
their thin-layer chromatography (TLC) profiles. Mix-
tures of ethyl acetate-methanol were used as elution as
follow: 8:2 for the crude extract and ethyl acetate frac-
tion; 10:1 for hexane fraction, 9:3 for n-butanol fraction
and 6:4 for the residue fraction. Spots and bands were
visualized by UV radiation (254 and 366 nm) and by
spraying with 50% (v/v) sulphuric acid reagent followed
by heating at 100°C.
Phytochemical screening
The phytochemical analysis of the crude extract and its
fractions were carried out using standard methods [19].
The plant material was screened for the presence of dif-
ferent classes of compounds including alkaloids, flavo-
noids, sterols, triterpenes, coumarins, anthraquinones,
tannins, anthocyanins, saponins and phenols.
In vitro Antidermatophytic activity
Preparation of dermatophyte inocula
The spore suspensions used for the inoculation were pre-
pared from a 15 days old cultures on Sabouraud Dextrose
Agar (Conda, Madrid, Spain) culture medium. The cul-
ture surfaces were gently scraped and placed in test
tubes containing 10 mL of sterile saline; then homoge-
nized by end-to-end mixing for 5 minutes and filtered.
The absorbances of the spore suspensions (filtrates)
were read at 530 nm and adjusted with sterile distilled
water between 0.15 and 0.17 to match 0.6 × 106 -1.4 ×
106 CFU.mL-1 [20].
Antidermatophytic activity using the well diffusion method
The well diffusion test was carried out as previously
described [21]. Briefly, stock solutions of the extracts
(crude extract and fractions) were prepared in 5% v/v
aqueous dimethyl sulphoxide (DMSO, Fisher Chemicals)at a concentration of 100 mg.mL-1. Glass bottles, each
containing 19.8 mL of sterile, matten Sabouraud Dextrose
Agar medium were maintained in a water bath set at
40°C (to prevent solidification of the medium) and then
inoculated aseptically with 0.2 mL of a given spore sus-
pension followed by thorough mixing. Each 20 mL mix-
ture was poured into a sterile Petri dishe (90 mm of
diameter) and allowed to solidify. A wells of 6 mm in
diameter was then made in the middle of SDA plate and
filled with 50 μl of an extracts prepared at 50 mg.mL-1.
The inoculated plates were then incubated at 30°C for
five days. The susceptibility was recorded by measuring
the diameter of the clear zone of growth inhibition on
the agar surface around each well. All the experiments
were repeated thrice: Griseofulvin (Merck, Darmstadt,
Germany) at 10 μg/well was used as positive control
while the dilution solution (5% (v/v) aqueous DMSO)
served as negative control.
Antidermatophytic activity using broth microdilution
method
The broth microdilution method [22] was used to deter-
mine the minimum inhibitory concentration (MIC) and
minimum fungicidal concentration (MFC) of the tested
substances using 96 well microplates (Nunclon, Roskilde,
Danmark). Two-fold serial dilutions of the extract
(Concentration range: 8–0.0625 mg.mL-1), fractions
(Concentration range: 1–0.0078 mg.mL-1) and reference
drug (Concentration range: 0.1-0.00078 mg.mL-1) were
performed in Sabouraud Dextrose Broth (SDB) in a total
volume of 200 μL per well. Each well contained 100 μL
of the test substance at a particular concentration, and
100 μL of the fungal spore suspension corresponding to
approximately 104 CFU.mL-1. The microwell plates were
covered and incubated at 30°C for five days on a plate
shaker (Flow Laboratory, Germany) at 300 rpm. Fungal
growth in each well was determined by observing and
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positive and negative controls. The MIC was the lowest
concentration of the test substance that prevented visible
growth of the microorganisms.
The minimum fungicidal concentration (MFC) va-
lues were determined by subculturing 50 μL aliquots
of the preparations, which did not show any visible
growth of the micro-organisms during MIC determi-
nations. These preparations were further incubated at
30°C for five days on the plate shaker at 300 rpm. Mi-
crobial growth in each well was determined by obser-
ving and comparing the turbidity of test wells to that
of the positive and negative controls. The MFC was
the lowest concentration of the test substances that
prevented visible growth of the microorganisms in the
sub-cultures. For every experiment, sterility controls
(5% v/v aqueous DMSO, medium, inocula and gri-
seofulvin) were included. All the experiments were
performed in triplicates.Table 3 Diameter of the inhibition zones (mm) of CH2Cl2-MeO
Polyscias fulva
Microorganisms Diameter of inhibitio
Crude extract Hexane fraction Ethyl acetate fra
T. mentagrophytes 28.0 ± 0.5b 0,0 ± 0.0a 29.0 ±0.5c
T. ajelloi 28.0 ± 0.4b 7.0 ± 0.3a 28.5±0.5b
T. rubrum 24.0 ± 0.4c 0.0 ± 0.0a 24.5±0.5c
T. equinum 25.4 ± 0.4c 0.0 ± 0.0a 25.4±0.4c
T. terrestre 25.0 ± 0.5c 0.0 ± 0.0a 22.0 ±0.3c
E. flocosum 21.5 ± 0.5b 20.0 ± 0.5a 23.0 ±0.5c
M. gypseum 20.3 ± 0.3b 0.0 ± 0.0a 20.2±0.2b
M. audouinii 28.1 ± 0.3b 0.0 ± 0.0a 29.0 ±0.5c
The results are the mean values of triplicate tests. Across the line, values aff
(test of Waller-Duncan (p > 0.05).In vivo study
Ethical statement
All studies involving animals were conducted according to
the ethical guidelines of the Committee for Control and
Supervision of Experiments on Animals (Registration no.
173/CPCSEA, dated 28 January, 2000), Government of
India, on the use of animals for scientific research.
Skin irritation test
The degree of dermal irritation of the dichloromethane-
methanol (1:1v/v) extract from the stem bark of Polyscias
fulva was determined in guinea pigs using the occluded
dermal irritation test method [23]. Twelve guinea pigs (six
males and six females) were used and each animal served
as its own control. They were divided into two groups
(group 1 and group 2) of six animals each (3 males and 3
females) and treated with water-moistened extract and
oil-moistened extract respectively. On day 0, fur wasH (1:1v/v) crude extract and fractions of the stem bark of
n zones ± Standard deviation (mm)
ction n-butanol fraction Residue fraction Griseofulvin (10 μg)
29.0 ±0.5c 28.1 ±0.2b 34.75±0.25d
28.5±0.5b 28.0 ± 0.2b 30.5±0.5c
24.4±0.2c 23.0 ±0.4b 30±0.5d
25.0 ±0.5c 24.5±0.5c 27.5±0.5d
21.0 ±0.3b 22.0 ±0.5c 35.83±0.28e
23.0 ±0.5c 22.0 ±0.5b 35±0.5d
21.0 ±0.3c 21.0 ±0.5c 34.7±0.20d
29.1 ±0.2c 28.1±0.3b 34.75±0.25d





























































Figure 1 Evolution of lesion scores during treatment of infected guinea pigs: females (1a) and males (1b). G: Griseofulvin-oil; KPOC: Palm
Kernel oil control; NC: Negative control; SC: Simple control (Non infected or non treated).
Table 4 Minimum Inhibitory Concentration (MIC in mg.mL-1) and Minimum Fungicidal Concentration (MFC in mg.mL-1)
of CH2Cl2-MeOH (1:1v/v) extract and fractions of the stem bark of Polyscias fulva
Microorganisms Crude extract Hexane fraction Ethyl acetate fraction n-butanol fraction Residue fraction Griseofulvin (10 μg)
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC
T. mentagrophytes 0.25 0.25 4 4 0.125 0.125 0.125 0.125 0.125 0.125 0.00078 0.00078
T. ajelloi 0.25 0.25 2 2 0.25 0.5 0.125 0.125 0.125 0.5 0.0003 0.0003
T. rubrum 0.5 0.5 8 ›8 0.25 0.25 0.25 0.25 0.5 0.5 0.0003 0.0003
T. equinum 0.5 0.5 4 8 0.5 0.5 0.25 0.25 0.25 0.25 0.0003 0.0003
T. terrestre 1 1 8 ›8 0.5 0.5 0.25 0.25 0.25 0.25 0.05 0.1
E. flocosum 1 1 1 1 0.125 0.25 0.25 0.5 0.25 0.5 0.0003 0.0003
M. gypseum 1 1 8 ›8 0.5 0.5 0.25 0.25 0.125 0.25 0.0015 0.0015
M. audouinii 0.5 0.5 4 8 0.125 0.25 0.25 0.25 0.125 0.5 0.00078 0.00078
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sides. The left side served as a negative control, while the
right one served as a test site. The guinea pigs were caged
individually for 24 h. On day 1, the extract (0.5 g) moist-
ened with distilled water was evenly applied to the test
sites of group 1 animals and the skin was covered with a
gauze patch, plastic sheet and a non-irritant adhesive plas-
ter. The control sites were treated with distilled water and
covered as above. The animals of group 2 were treated
with oil-moistened extract in the same manner as above.
Palm kernel oil was used and also served as the negative
control for the group 2 experiment.
After 24 h of exposure, the coverings were removed
and the test site rinsed with distilled water and dried.
The animals were examined for the presence of ery-
thema and edema according to the Draize dermal irrita-
tion scoring system (0, no erythema or no edema; 1,
barely perceptible erythema or edema; 2, well defined
erythema or slight edema; 3, moderate to severe ery-
thema or moderate edema; 4, severe erythema or edema)
at grading intervals of 1, 24, 48 and 72 h [24].
The primary irritation index (PII) was calculated by
dividing the sum of erythema and edema scores of the
grading intervals by the number of grading intervals (4).
The extract was then classified according to the Draize
method of classification using the PII scoring method as
mildly irritant (PII< 2), moderately irritant (2 ≤PII≤ 5),
and severely irritant (PII>5).
In vivo antidermatophytic activity
This experiment was carried out using the crude extract.
The fungal inoculum was prepared as described above in
the section on in vitro antidermatophytic activity.Animals six days post infection
Animals after fifteen days of treatment 
Figure 2 Comparative illustration of the evolution of the infection du
1: Uninfected animal. 2: Infected untreated animal. 3: Infected animal treated
of griseofulvin-oil at 5%. 5: Infected animal treated with 0.1 g/kg of extract-oil
7: Infected animal treated with 0.1 g/kg of extract-oil at 5%.Dermal infection of animals
Both male and female guinea pigs (350-450 g) were used.
The fur from the back of each guinea pig was shaved
(approximately 16 cm2) and 50 μL of a suspension of T.
Mentagrophytes spores was inoculated to a surface of
about 4 cm2 area (previously lightly abraded with sand-
paper) within the shaved zone [20,25]. Animals were
randomly assigned to different treatment groups. For
each sex, there were seven groups of three animals each.
Evidence of infection was revealed by direct observation
of the infected area, followed by agar culture of scrap-
ings from the area, and microscopic observation of the
resulting fungi from the scrapings.
Treatment of infected animals
Animals were treated by dermal application of the test
substance which started on the sixth day after animal in-
fection and was continued daily (each morning). All ani-
mals except those of group 1 were infected and treated
(Table 1).
Clinical surveillance of treatment
Clinical response was monitored by assigning a score be-
tween 0 and 4 to each infection site: 1 (for flakinsg skin
with mild inflammation); 2 (for slight lesions with mod-
erate inflammation); 3 (for moderate lesions with severe
inflammation) and 4 (for severe inflammation plus crust
formation). The results were expressed as the percentage
reduction in mean lesion score at the time when
placebo-treated (group 3) animals showed maximal se-
verity (lesion score 4) [26].
The degree to which the animals complied with
treatment was estimated by culturing skin scrapingsAnimals after ten days of treatment 
Animals after nineteen days of treatment
ring treatment of infected guinea pigs with P. fulva extract-oil.
with 0.1 g/kg of palm Kernel oil. 4: Infected animal treated with 0.01 g/kg
at 1.25%. 6: Infected animal treated with 0.1 g/kg of extract-oil at 2.5%.
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with actidione (Conda), for recovery of viable T.
Mentagrophytes cells. These scrapings and fur were
collected from the active border of the infection site
every two days [27]. The cultures were incubated for
15 days at 28°C. The results were recorded in terms of
percentage culture recovery of T. Mentagrophytes of
the infected site [14].
% Culture recovery ¼
Total number of sites showing
presence of dermatophytes
Total number of infection sites
 100
Statistical analysis
Data on irritation are presented as visual scores based
on Draize method of erythema and edema-gradingFigure 3 Evolution of the percent culture recovery during treatment
G: Griseofulvin-oil; KPOC: Palm Kernel oil control; NC: Negative control; SC:system and PII was calculated, whereas the inhibition di-
ameters of crude extract and fractions were expressed as
the mean ± standard deviation. The Waller-Duncan test
was used to compare the means for the different sub-
stances tested, at 5% significance level.
Results
Phytochemical screening of extract and fractions
The phytochemical screening revealed that all the classes
of compounds (saponins, tannins, alkaloids, anthraquin-
one and phenols) present in the crude extract were
found in the ethyl acetate fraction (Table 2). The hexane
fraction had only alkaloids. The n-butanol and residue
fractions had almost the same composition except that
anthraquinones were present in n-butanol fraction, while
alkaloids were in the residual fraction.of infected guinea pigs: females (3a) and males (3b).
Simple control (Non infected or non treated).
Figure 5 Degree of irritation and it trends of change since
opening of the patch 24 h after dermal application of 0.5 g of
dichloromethane-methanol (1:1v/v) extract from the stem bark
of Polyscias fulva.
Figure 4 Illustration of the irritant effect of Polyscias fulva
extract moistened with distilled water.
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As revealed by the well diffusion method, the n-hexane
fraction was almost inactive on all the tested microor-
ganisms except E. floccosum. All the microorganisms
appeared to be sensitive to the active substances with T.
mentagrophytes, T. ajelloi and M. audouinii being the
most sensitive (Table 3). Fractionation did not signifi-
cantly increase antidermatophytic activities. These re-
sults were globally confirmed by the microdilution
method for determination of MIC and MFC (Table 4),
although on some species, fractions were more active.
The MFC/MIC ratios were less than or equal to 2,
indicating a possible fungicidal effect of the extract and
its fractions.
In vivo Antidermatophytic assay
Only infected animals were used in this assay. Up to the
sixth day of treatment, lesions increased continuously in
all the groups. From the 8th day, the intensity of lesions
started dropping in the treated groups in a dose-
dependent manner (Figures 1 and 2). The Griseofulvin-
oil (5%) and extract-oil (5%) mixtures had comparable
effects, eradicating surface lesions after 13 and 14 days
of treatment respectively. However, the other doses
gradually overcome the infection from the 17th day
of treatment. Simultaneously, lesions continued to
increase in the untreated groups (negative control
and the vehicle-treated group), indicating the non-
therapeutic effect of the vehicle. These results corrob-
orate the percentage culture recovery experiment as
there were no more fungal cells at the infection sites
from the 14, 15, 17 and 19th days of treatment for
griseofulvin-oil (5%), extract-oil at 5%, 2,5% and 1,25%
respectively (Figure 3).
Skin irritation test
Group 1 animals did not show observable edema while
barely perceptible erythema effects (PII = 0.54) were evi-
dent in guinea pigs of this group (Figure 4). Neither vis-
ible erythema nor edema were observed in the guinea
pigs of group 2 (PII = 0.00). These results indicate that
the use of palm kernel oil as a vehicle is preferable to
water. The time course of recovery from irritation is
depicted in Figure 5. Scores of erythema following 1 and
2 h after the opening of the patch were similar in intensity.
However, the erythema score had sharply decreased and
came to zero at the 72 h reading in group 1 (Figure 5).
There was no erythema or edema observed on the control
sites of all guinea pigs.
Discussion
Antidermatophytic activity
Dermatophytes are closely related fungi which induce
dermatophytosis. Treatment with topical fungicidal
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[28]. Although not life threatening, dermatophytosis are
difficult to eradicate, particularly in low income coun-
tries, due to the non-accessibility to efficient drugs and
ignorance. In these countries, these diseases are mostly
treated using medicinal plants. Herbal medicines have
been important sources of bioactive substances belong-
ing to diverse chemical groups [29]. The phytochemical
screening of the crude extract of P. fulva and its frac-
tions revealed the presence of saponins, tannins, alka-
loids, anthraquinone and phenols that can explain their
antidermatophytic activities. Individual activities of these
compounds have been demonstrated [29]. Also, from
our previous work, the antidermatophytic activities of
triterpenes [30], essential oil of Ageratum houstonianum
[31] and the volatile fraction of Cupressus lusitanica,
constituted of monoterpens, sesquiterpens and triterpens
[32], were reported. The n-hexane fraction was almost
inactive, indicating that the active principle may not be-
long to the family of alkaloid.
Trichophytosis induced in guinea pigs is a well-
established predictive model for testing topical antifun-
gal agents [25]. This model was used in this study and
permitted to show that the crude extract of P. fulva
possesses in vivo antifungal activity against a virulent
strain of T. mentagrophytes. Irrespective of sex, the
extract-oil formulation at 5% was able to cure infected
animals after fourteen days of treatment while griseo-
fulvin produced the same effect after thirteen days.
These results show that, this formulation can be used
as a substitute or an alternative to the use of griseo-
fulvin to cure dermatophytosis. It can therefore be a po-
tent candidate for the elaboration of a phytomedicine.
Similar results have been reported on the antidermato-
phytic action of a 1% oil-petroleum gelly formula-
tion of the essential oil of Chenopodium ambroisoides
which cured Trichophyton mentagrophytes-induced
dermatophytosis in guinea pigs in 15 days [13]. Also
similar effects have been reported on the extract-cream
formulation of Zataria multiflora [14] and Eucalyptus
camaldulensis [15].
In dermatophytic infections as observed in this study,
inflammatory responses are usually characterized by a
greater degree of redness and scaling at the edges of
the lesions, or occasionally, blister formations [28]. This
is often accompanied by mild irritation though, could
be more severe with some types of fungal infection.
During inflammation, reactive oxygen species and free
radicals with many physiological and pharmacological
adverse effects, including skin irritation are produced
[33]. The phenols and tannins, identified in the P. fulva
extract, are known for their ability to protect cells
against reactive oxygen species and free radical-induced
toxicity [34].Skin irritation test
The irritation test revealed a negligible irritant effect of
the extract at a high dose (0.5 g) on guinea pig’s skin.
The low level of erythema observed quickly decreased
after the opening of the occlusion. This can be attributed
to the occlusion effect of the extract; a phenomenon
known to boost phase I or the vascular event of an in-
flammatory response [35]. Occurrence of phase II or the
cellular event of the inflammatory process was not
evident in our study since there were no observable
changes in the skin morphology of the guinea pigs. This
confirms the assertion that the extract would have only
a negligible irritation potential [36,37]. Similar results
have been reported on the skin irritation test of an 80%
methanol extract of the leaf of Dodonaea viscose in rab-
bits where the primary irritation index was 0.45 [35].
The fact that neither erythema nor edema persisted in
the guinea pigs could lend support to the fact that this
plant extract is safe at the indicated dose. Also the
absence of these clinical signs in the palm kernel oil-
treated group suggests that use of this oil as a vehicle for
administering this extract, is safe.
Conclusion
This study demonstrates that the crude dichloromethane-
methanol (1:1 v/v) extract from the stem bark of Polyscias
fulva possesses antidermatophytic properties without irri-
tation effects. These results may justify the use of Polyscias
fulva in the traditional medicine to cure dermatoses.
Besides, palm kernel oil has been demonstrated to be a
good vehicle. The oil-extract of Polyscias fulva may be a
possible candidate for the standardization of an anti-
dermatophytic phytomedicine or for the isolation of phar-
macologically active antifungal agents.
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